Successful launch of Inify Laboratories’ services, with first patient cases diagnosed

Investor News 2023-06-20
“The beginning of a paradigm shift within pathology” STOCKHOLM – June 20, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, announces the opening of its first laboratory, having delivered its first prostate cancer diagnoses. “We are extremely proud to have launched successfully and according to plan. We have now […]
Read More

Inify Laboratories AB (publ) – summary of Annual General Meeting

Annual General Meeting, Investor News 2023-05-17
Inify Laboratories, held its ordinary Shareholders’ Annual General Meeting at the company's premises on May 16, 2023. A total of 34,075,774 shares were represented at the Annual General Meeting, corresponding to 75.3% of the total number of shares and votes. The AGM resolved, with the required majority, on all matters in accordance with the Board of Directors's published proposal. Below is a summary of the main decisions made, for further details please refer to the notice available on the company's website.
Read More

Inify Laboratories – Annual Report 2022

Annual reports, Financial reports, Investor News 2023-04-12
Stockholm – April 12, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, 2022. The annual report is attached to this press release and is also available on the company’s website: www.inify.com. Printed copies of the report will […]
Read More

Inify Laboratories – notice of Annual General Meeting on May 16, 2023

Annual General Meeting, Investor News 2023-04-12
Stockholm – April 12, 2023 – Inify Laboratories AB (publ), a company providing fully digitalized laboratory services within prostate cancer diagnostics, hereby invites its shareholders to Annual General Meeting on May 16, 2023. Please find attached the invitation including agenda and details on how to register and vote. The invitation is also available on the […]
Read More

Panel talk about Inify’s fourth quarter 2022

Investor News 2023-02-23
During the last quarter of 2022, Inify Laboratories moved into its brand-new premises at Campus Solna just outside of Stockholm. The laboratory was finished in record time and all essential milestones were reached, in terms of both laboratory infrastructure as well as IT solutions and processes. In this panel talk, led by Ole Eikeland, the […]
Read More

Inify Laboratories – Ultramodern AI-based digital pathology laboratory completed in record time

Financial reports, Investor News 2023-02-22
STOCKHOLM – February 22, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, has completed its new laboratory – including staffing up with skilled professionals – in less than a year. “The laboratory has been finished in record time. We now have an ultramodern AI-based laboratory, and a dedicated […]
Read More

Panel talk about Inify’s third quarter

Investor News 2022-11-09
The third quarter of 2022 saw progress in several areas, such as the construction of the laboratory facilities in Campus Solna in Stockholm, the setup of a simulation laboratory in Linköping and the recruitment of skilled personnel, including that of Dr. Claes Lindh, the company’s new Chief Medical Officer (CMO) as of September. Some highlights of […]
Read More

Inify Laboratories – Laboratory and recruitment on track with positive market feedback

Financial reports, Investor News 2022-10-26
STOCKHOLM – October 26, 2022 Inify Laboratories, a fully integrated digital ultramodern laboratory services within pathology that provides cancer diagnostics, is advancing towards opening of the company’s new laboratory, situated on Campus Solna close to Karolinska Institutet in Stockholm. “In an impressively short time, we have built a simulation lab where we further improve, test […]
Read More